Common Contracts
2 similar Exclusive Research, Development, License and Manufacturing and Supply Agreement contracts by Nektar Therapeutics
ContractExclusive Research, Development, License and Manufacturing and Supply Agreement • May 5th, 2020 • California
EX-10.34 11 c82049exv10w34.htm EXHIBIT 10.34 Exhibit 10.34 FOIA CONFIDENTIAL TREATMENT REQUESTED EXCLUSIVE RESEARCH, DEVELOPMENT, LICENSE AND MANUFACTURING AND SUPPLY AGREEMENT BY AND AMONG NEKTAR THERAPEUTICS AL, CORPORATION AND BAXTER HEALTHCARE SA AND BAXTER HEALTHCARE CORPORATION DATED SEPTEMBER 26, 2005
EXCLUSIVE RESEARCH, DEVELOPMENT, LICENSE AND MANUFACTURING AND SUPPLY AGREEMENT BY AND AMONG NEKTAR THERAPEUTICS AL, CORPORATION AND BAXTER HEALTHCARE SA AND BAXTER HEALTHCARE CORPORATION DATED SEPTEMBER 26, 2005Exclusive Research, Development, License and Manufacturing and Supply Agreement • March 6th, 2009 • Nektar Therapeutics • Pharmaceutical preparations • California
This Agreement (this “AGREEMENT”) is made and entered into as of September 26, 2005 (the “EFFECTIVE DATE”) by and among Nektar Therapeutics AL, Corporation, an Alabama corporation, having its principal place of business at 490 Discovery Drive, Huntsville, AL 35806 (“NEKTAR AL”), Baxter Healthcare SA (“BHSA”), a corporation organized and existing under the laws of Switzerland, and Baxter Healthcare Corporation (“BHC”), a Delaware corporation, having its principal place of business at One Baxter Parkway, Deerfield, Illinois 60015 (BHSA and BHC collectively referred to as “BAXTER”). NEKTAR AL and BAXTER may be referred to herein individually as a “PARTY” and collectively as the “PARTIES.”
